do glp 1 help insulin resistance GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Frontiers | GLP−1 receptor agonists

Description

In an uncontrolled study in people with T2D, liraglutide initially lowered eGFR (35), but this result was not confirmed in placebo-controlled studies that assessed mGFR and kidney hemodynamic function by gold-standard tracer methods (36)

This provides more time to assess disease stability before adding metabolic stress

"Our data shows that several metabolic markers begin to shift early in treatment, often before patients reach the 5 per cent or 10 per cent weight-loss thresholds typically considered clinically significant." Rethinking success Doctors say the public conversation around GLP-1 medications has not always kept pace with the science